We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $570B
1-Year Est. Return 27.57%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
-13.35%
1 Year Est. Return
+27.57%
3 Year Est. Return
+75.99%
5 Year Est. Return
+94.97%
10 Year Est. Return
+325.25%
AUM
$340B
AUM Growth
-$60.4B
Cap. Flow
-$1.31B
Cap. Flow %
-0.39%
Top 10 Hldgs %
20.28%
Holding
8,274
New
398
Increased
2,517
Reduced
3,856
Closed
651

Sector Composition

Rank Sector Weight
1 Financials 20.3%
2 Technology 11.83%
3 Healthcare 8.85%
4 Energy 7.86%
5 Industrials 7.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
III icon
6976
Information Services Group
III
$249M
$1K ﹤0.01%
200
-10,497
-98% -$66.1K
IMA
6977
ImageneBio Inc
IMA
$68M
$1K ﹤0.01%
16
-126
-89% -$6.95K
HYFT
6978
MindWalk Holdings
HYFT
$65.3M
$1K ﹤0.01%
300
IPSC icon
6979
Century Therapeutics
IPSC
$355M
$1K ﹤0.01%
114
-951
-89% -$9.33K
IVVD icon
6980
Invivyd
IVVD
$216M
$1K ﹤0.01%
289
-3,329
-92% -$10.4K
JANX icon
6981
Janux Therapeutics
JANX
$978M
$1K ﹤0.01%
97
-995
-91% -$11.8K
JMSB icon
6982
John Marshall Bancorp
JMSB
$328M
$1K ﹤0.01%
+64
New +$1.66K
KALV
6983
DELISTED
KalVista Pharmaceuticals
KALV
$1K ﹤0.01%
138
-1,238
-90% -$13.7K
TBHC
6984
DELISTED
The Brand House Collective
TBHC
$1K ﹤0.01%
200
-777
-80% -$4.97K
KMDA icon
6985
Kamada
KMDA
$397M
$1K ﹤0.01%
175
-314
-64% -$1.55K
KRT icon
6986
Karat Packaging
KRT
$962M
$1K ﹤0.01%
32
-249
-89% -$4.66K
LABU icon
6987
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$623M
$1K ﹤0.01%
5
LEXX icon
6988
Lexaria Bioscience
LEXX
$10.1M
$1K ﹤0.01%
26
LND
6989
BrasilAgro
LND
$348M
$1K ﹤0.01%
+200
New +$1.29K
CYPH
6990
Cypherpunk Technologies Inc
CYPH
$70.9M
$1K ﹤0.01%
100
-1
-1% -$13
LSF icon
6991
Laird Superfood
LSF
$46.8M
$1K ﹤0.01%
535
+78
+17% +$213
LTRN icon
6992
Lantern Pharma
LTRN
$33.9M
$1K ﹤0.01%
132
-1,158
-90% -$6.91K
LVLU icon
6993
Lulu's Fashion Lounge
LVLU
$48.5M
$1K ﹤0.01%
10
-14
-58% -$2.47K
MDWD icon
6994
MediWound
MDWD
$179M
$1K ﹤0.01%
42
-18
-30% -$238
MGNX icon
6995
MacroGenics
MGNX
$256M
$1K ﹤0.01%
339
-5,950
-95% -$31.3K
NAUT icon
6996
Nautilus Biotechnolgy
NAUT
$113M
$1K ﹤0.01%
270
-1,827
-87% -$6.8K
NC icon
6997
NACCO Industries
NC
$317M
$1K ﹤0.01%
23
-36
-61% -$1.72K
NEON icon
6998
Neonode
NEON
$16.6M
$1K ﹤0.01%
190
NGS icon
6999
Natural Gas Services Group
NGS
$474M
$1K ﹤0.01%
+52
New +$664
NINE
7000
DELISTED
Nine Energy Service
NINE
$1K ﹤0.01%
350
-1,000
-74% -$3.01K

Similar funds

Royal Bank of Canada's Q2 2022 Portfolio in Review

As of Q2 2022, Royal Bank of Canada held 8,274 positions worth $340B, down 15% from $400B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Royal Bank of Canada's Q2 2022 filing shows 398 new, 2,517 increased, 3,856 reduced and 651 closed positions. Its largest new stake was Aspen Technology Inc: 92,306 shares worth $17M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $558M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.

  • Royal Bank of Canada's largest Q2 2022 buy was Aspen Technology Inc: 92,306 shares worth $17M.
  • Royal Bank of Canada added most to iShares Core S&P 500 ETF in Q2 2022, an estimated $866M increase.
  • Royal Bank of Canada's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $558M.
  • Royal Bank of Canada fully exited Discovery, Inc. Series C Common Stock in Q2 2022, selling an estimated $45.7M.
  • Royal Bank of Canada's ten largest holdings make up 20% of its $340B portfolio in Q2 2022.
  • Royal Bank of Canada opened 398 new positions and closed 651 in Q2 2022.
  • Royal Bank of Canada's portfolio value fell 15% quarter-over-quarter to $340B.

Based on Royal Bank of Canada's 13F filing for Q2 2022, filed 15 Aug 2022.